Abstract:Circulation Research, Ahead of Print. BACKGROUND:CNP (C-type natriuretic peptide), an endogenous short peptide in the natriuretic peptide family, has emerged as an important regulator to govern vascular homeostasis. However, its role in the development of atherosclerosis remains unclear. This study aimed to investigate the impact of CNP on the progression of atherosclerotic plaques and elucidate its underlying mechanisms.METHODS:Plasma CNP levels were measured in patients with acute coronary syndrome. The potential atheroprotective role of CNP was evaluated in ApoE−/−mice through CNP supplementation via osmotic pumps, genetic overexpression, or LCZ696 administration. Various functional experiments involving CNP treatment were performed on primary macrophages derived from wild-type and CD36 knockout mice. Proteomics and multiple biochemical analyses were conducted to unravel the underlying mechanism.RESULTS:We observed a negative correlation between plasma CNP concentration and the burden of coronary atherosclerosis in patients. In early atherosclerotic plaques, CNP predominantly accumulated in macrophages but significantly decreased in advanced plaques. Supplementing CNP via osmotic pumps or genetic overexpression ameliorated atherosclerotic plaque formation and enhanced plaque stability in ApoE−/−mice. CNP promoted an anti-inflammatory macrophage phenotype and efferocytosis and reduced foam cell formation and necroptosis. Mechanistically, we found that CNP could accelerate HIF-1α degradation in macrophages by enhancing the interaction between PHD (prolyl hydroxylase domain–containing protein) 2 and HIF-1α. Furthermore, we observed that CD36 bound to CNP and mediated its endocytosis in macrophages. Moreover, we demonstrated that the administration of LCZ696, an orally bioavailable drug recently approved for treating chronic heart failure with reduced ejection fraction, could amplify the bioactivity of CNP and ameliorate atherosclerotic plaque formation.CONCLUSIONS:Our study reveals that CNP enhanced plaque stability and alleviated macrophage inflammatory responses by promoting HIF-1α degradation, suggesting a novel atheroprotective role of CNP. Enhancing CNP bioactivity may offer a novel pharmacological strategy for treating related diseases.

C-type Natriuretic Peptide Attenuates LPS-induced Endothelial Activation: Involvement of P38, Akt, and NF-κB Pathways.

Activation of Epac Alleviates Inflammation and Vascular Leakage in LPS-induced Acute Murine Lung Injury.

CXCL13 is Involved in the Lipopolysaccharide-Induced Hyperpermeability of Umbilical Vein Endothelial Cells

CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis

Penehyclidine Hydrochloride Attenuates LPS-induced Inos Production by Inhibiting P38 MAPK Activation in Endothelial Cells

Hnrnpa2/b1 Ameliorates LPS-Induced Endothelial Injury Through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation in Vitro

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Cathelicidin-WA attenuates LPS-induced inflammation and redox imbalance through activation of AMPK signaling.

Suppression of Ca(2+) Influx in Endotoxin-Treated Mouse Cerebral Cortex Endothelial Bend.3 Cells.

Cardamonin from a Medicinal Herb Protects Against LPS-induced Septic Shock by Suppressing NLRP3 Inflammasome

Puerarin Prevents Vascular Endothelial Injury Through Suppression of NF-κB Activation in LPS-challenged Human Umbilical Vein Endothelial Cells

Lipocalin 10 is essential for protection against inflammation-triggered vascular leakage by activating LRP2-Ssh1 signaling pathway

Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction

C-type Natriuretic Peptide Inhibits Upregulation of Alpha1-Adrenoceptor and Inositol 1,4,5-Trisphosphate Receptor in Rat Vascular Smooth Muscle after Vascular Endothelial Injury.

C1 Inhibitor Prevents Gram-negative Bacterial Lipopolysaccharide-Induced Vascular Permeability.

Protectin conjugates in tissue regeneration 1 restores lipopolysaccharide-induced pulmonary endothelial glycocalyx loss via ALX/SIRT1/NF-kappa B axis

Suppression of complement regulatory protein C1 inhibitor in vascular endothelial activation by inhibiting vascular cell adhesion molecule-1 action.

Role of P38 MAPK Signal Pathway in Attenuation of Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cell Injury by Penehyclidine Hydrochloride

LCZ696 ameliorates lipopolysaccharide-induced endothelial injury

Impact of oxLDL and LPS on C-type Natriuretic Peptide System is Different between THP-1 Cells and Human Peripheral Blood Monocytic Cells

C-type Natriuretic Peptide Prevents Angiotensin II-induced Atrial Connexin 40 and 43 Dysregulation by Activating AMP-activated Kinase Signaling